HAIGH INSIGHTS
2024 BiotechEquity Report
AN OVERVIEW OF EQUITY UTILIZATION IN
LIFE SCIENCE COMPANIES THROUGH Q3 2024
HAIGH INSIGHTS
2023 BiotechEquity Report
AN OVERVIEW OF EQUITY UTILIZATION IN
LIFE SCIENCE COMPANIES THROUGH Q3 2023
To our life science industry colleagues,
We are pleased to present the Haigh & Company 2024 BiotechEquity Report.
The purpose of our analysis is to provide our clients, colleagues and the broader life sciences community an up-to-date look at equity
usage through the third quarter of 2024 and to provide a resource for your year-end planning process.
Some Key Results:
PLEASE DOWNLOAD FOR MORE INFORMATION
To our life science industry colleagues,
We are pleased to present the Haigh & Company 2023 BiotechEquity Report.
The purpose of our analysis is to provide our clients, colleagues and the broader life sciences community an up-to-date look at equity usage through the third quarter of 2023 and to provide a resource for your year-end and new year planning process.
Some Key Results:

PLEASE DOWNLOAD FOR MORE INFORMATION